Tirbanibulin

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 116 publications

Repurposing flufenamic acid as a putative PmrB-directed adjuvant to restore colistin activity in Klebsiella pneumoniae.

Repurposing flufenamic acid as a putative PmrB-directed adjuvant to restore colistin activity in Klebsiella pneumoniae.

Journal: Microbiology spectrum

Published: March 17, 2026

Comments on "Randomized comparative study of 5-Fluorouracil 4 %, tirbanibulin, and photodynamic therapy for relapsing actinic keratoses".

Comments on "Randomized comparative study of 5-Fluorouracil 4 %, tirbanibulin, and photodynamic therapy for relapsing actinic keratoses".

Journal: Photodiagnosis and photodynamic therapy

Published: March 13, 2026

Efficacy of acitretin, cryotherapy, and tirbanibulin combination therapy for recalcitrant plantar and periungual warts: a case series of 30 patients.

Efficacy of acitretin, cryotherapy, and tirbanibulin combination therapy for recalcitrant plantar and periungual warts: a case series of 30 patients.

Journal: Italian journal of dermatology and venereology

Published: January 14, 2026

Randomized comparative study of 5-Fluorouracil 4%, tirbanibulin, and photodynamic therapy for relapsing actinic keratoses.

Randomized comparative study of 5-Fluorouracil 4%, tirbanibulin, and photodynamic therapy for relapsing actinic keratoses.

Journal: Photodiagnosis and photodynamic therapy

Published: December 26, 2025

Holistic Value Assessment of Tirbanibulin for Actinic Keratosis: European Multi-Criteria Decision Analysis.

Holistic Value Assessment of Tirbanibulin for Actinic Keratosis: European Multi-Criteria Decision Analysis.

Journal: Dermatology and therapy

Published: November 04, 2025

Field Therapy for Actinic Keratosis: One Nurse Practitioner's Perspective on Evolving Approaches and Patient-centered Care.

Field Therapy for Actinic Keratosis: One Nurse Practitioner's Perspective on Evolving Approaches and Patient-centered Care.

Journal: The Journal of clinical and aesthetic dermatology

Published: August 22, 2025

Src and Abl as Therapeutic Targets in Lung Cancer: Opportunities for Drug Repurposing.

Src and Abl as Therapeutic Targets in Lung Cancer: Opportunities for Drug Repurposing.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: August 19, 2025

Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study).

Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study).

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV

Published: July 28, 2025

Tirbanibulin 1% Ointment: The Mechanism of Action of a Novel Topical Therapy for Actinic Keratosis.

Tirbanibulin 1% Ointment: The Mechanism of Action of a Novel Topical Therapy for Actinic Keratosis.

Journal: Journal of drugs in dermatology : JDD

Published: July 08, 2025

Tirbanibulin 1% Ointment: Clinical Trial and Real-World Evidence on Efficacy, Tolerability, Safety, and Patient-Reported Outcomes.

Tirbanibulin 1% Ointment: Clinical Trial and Real-World Evidence on Efficacy, Tolerability, Safety, and Patient-Reported Outcomes.

Journal: Journal of drugs in dermatology : JDD

Published: July 08, 2025

Local Chemotherapy of Skin Pre-Neoplastic Lesions and Malignancies from the Perspective of Current Pharmaceutics.

Local Chemotherapy of Skin Pre-Neoplastic Lesions and Malignancies from the Perspective of Current Pharmaceutics.

Journal: Pharmaceutics

Published: June 30, 2025

Tirbanibulin: An effective treatment for recalcitrant plantar warts.

Tirbanibulin: An effective treatment for recalcitrant plantar warts.

Journal: Medicina clinica

Published: June 20, 2025

Showing 1-12 of 116

Last Updated: 04/28/2026